资讯

See how small adjustments in basic juggling can lead to a more dynamic and visually appealing soccer performance.
Biocon Biologics secures USFDA approval for two denosumab biosimilars (Prolia/Xtiva), targeting $5B US market for osteoporosis/bone metastasis. CEO Siddharth Mitta eyes $200M+ revenue contribution by ...